Principal Financial Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $914K | Sell |
|
|||||
|
2024
Q4 | $46M | Sell |
|
|||||
|
2024
Q3 | $43.7M | Buy |
|
|||||
|
2024
Q2 | $39.6M | Buy |
|
|||||
|
2024
Q1 | $36.5M | Buy |
|
|||||
|
2023
Q4 | $33M | Buy |
|
|||||
|
2023
Q3 | $21.7M | Sell |
|
|||||
|
2023
Q2 | $26.5M | Buy |
|
|||||
|
2023
Q1 | $1.26M | Sell |
|
|||||
|
2022
Q4 | $1.32M | Sell |
|
|||||
|
2022
Q3 | $2.13M | Sell |
|
|||||
|
2022
Q2 | $11M | Buy |
|
|||||
|
2022
Q1 | $4.04M | Sell |
|
|||||
|
2021
Q4 | $3.48M | Buy |
|
|||||
|
2021
Q3 | $1.17M | Buy |
|
|||||
|
2021
Q2 | $1.22M | Buy |
|
|||||
|
2021
Q1 | $835K | Buy |
|
|||||
|
2020
Q4 | $728K | Buy |
|
|||||
|
2020
Q3 | $353K | Sell |
|
|||||
|
2020
Q2 | $359K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $276K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $247K | Buy |
|